诊断性超声指导高胎盘植入谱系障碍风险患者剖宫产手术方式的选择
本研究分析了2023年9月至2024年8月前瞻性收集的高胎盘植入谱系障碍风险病例,评估超声标志物预测剖宫产子宫切除术需求的价值。在123例参与者中,子宫保留手术在93例胎盘植入谱系障碍病例中成功74例(79.6%),在30例非胎盘植入瘢痕裂开病例中成功100%。LASSO回归显示宫颈内富血供>50%、膀胱壁扭曲和宫旁富血供是子宫切除术的最重要预测因素,联合宫颈内富血供>50%和膀胱壁扭曲预测子宫切除术的概率最高为0.87(95%CI 0.81-0.93),敏感度96.0%(95%CI 89.0%-99.0%),特异度92.0%(95%CI 62.0-100.0)。
要点
- 子宫保留手术在93例胎盘植入谱系障碍病例中成功74例(79.6%),在30例非胎盘植入瘢痕裂开病例中成功100%。
- 宫颈内富血供>50%、膀胱壁扭曲和宫旁富血供是子宫切除术的最重要预测因素。
- 联合宫颈内富血供>50%和膀胱壁扭曲预测子宫切除术的概率为0.87(95%CI 0.81-0.93)。
核心结论
- 全面的术前超声可以合理预测胎盘植入谱系障碍的适当手术方式。
- 通过联合经腹部、经阴道和彩色多普勒超声技术评估宫颈内富血供和膀胱壁扭曲可实现这一预测,因为这些征象与以子宫保留手术为意向治疗的队列中子宫切除术需求强相关。
研究设计与样本
- 本研究为对2023年9月至2024年8月前瞻性收集的高胎盘植入谱系障碍风险病例数据的分析。
- 共纳入123例参与者:93例胎盘植入谱系障碍病例和30例非胎盘植入瘢痕裂开病例。
- 超声检查由专注于胎盘植入谱系障碍诊断的专家进行。
- 所有患者均被告知本中心可用的管理选择,即子宫保留手术和子宫切除术;所有患者若安全且技术可行均选择子宫保留手术。
- 手术管理方式的最终选择完全基于术中地形学,即异常粘连胎盘的大小和位置。
主要发现
- 子宫保留手术在93例胎盘植入谱系障碍病例中成功74例(79.6%),在30例非胎盘植入瘢痕裂开病例中成功100%。
- LASSO惩罚回归显示宫颈内富血供>50%、膀胱壁扭曲和宫旁富血供是子宫切除术的最重要预测因素。
- 最佳拟合模型在模型交叉验证后达到94%的准确率(95%CI 81.3%-99.3%)。
- 联合宫颈内富血供>50%和膀胱壁扭曲对子宫切除术的预测概率最高,值为0.87(95%CI 0.81-0.93),敏感度96.0%(95%CI 89.0%-99.0%),特异度92.0%(95%CI 62.0-100.0)。
关键数值与推荐
- 宫颈内富血供>50%、膀胱壁扭曲和宫旁富血供被确定为子宫切除术的最重要预测因素。
- 联合宫颈内富血供>50%和膀胱壁扭曲预测子宫切除术的概率为0.87(95%CI 0.81-0.93)。
- 联合宫颈内富血供>50%和膀胱壁扭曲预测子宫切除术的敏感度为96.0%(95%CI 89.0%-99.0%),特异度为92.0%(95%CI 62.0-100.0)。
- 最佳拟合模型交叉验证后准确率为94%(95%CI 81.3%-99.3%)。
临床怎么用
- 术前全面超声可通过评估宫颈内富血供和膀胱壁扭曲来合理预测胎盘植入谱系障碍的适当手术方式。
- 评估宫颈内富血供和膀胱壁扭曲需联合经腹部、经阴道和彩色多普勒超声技术。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Uterine-sparing surgery has become an option for patients with placenta accreta spectrum disorders. The decision to perform a cesarean hysterectomy vs uterine-sparing surgery is made intraoperatively. This study was undertaken to assess the value of ultrasound markers in predicting the need for hysterectomy. OBJECTIVE: This study aimed to describe ultrasound markers associated with the need for cesarean hysterectomy among patients at risk of placenta accreta spectrum. STUDY DESIGN: This was an analysis of prospectively collected data of high-risk placenta accreta spectrum cases between September 2023 and August 2024. Ultrasound examination was performed by an expert focusing on the diagnosis of placenta accreta spectrum. All patients were counseled regarding the management options available at our center, namely uterine-sparing surgery and hysterectomy. All patients opted for uterine-sparing surgery if safe and technically feasible. The final choice of surgical management approach was solely based on the intraoperative topography, which describes the size and location of the abnormally adherent placenta. The primary outcome was the need for hysterectomy despite a preoperative plan for uterine-sparing surgery. RESULTS: A total of 123 participants were enrolled: 93 placenta accreta spectrum cases and 30 non-placenta accreta scar dehiscence cases. Uterine-sparing surgery was successful in 74 of 93 (79.6%) placenta accreta spectrum cases and in 100% of non-placenta accreta scar dehiscence cases. LASSO (least absolute shrinkage and selection operator) penalized regression revealed intracervical hypervascularity >50%, urinary bladder wall distortion, and parametrial hypervascularity as the most influential predictors for hysterectomy. This best-fitted model achieved an accuracy of 94% (95% confidence interval, 81.3%-99.3%) after model cross-validation. The combination of intracervical hypervascularity >50% and bladder wall distortion had the highest predictive probability for hysterectomy, with a value of 0.87 (95% confidence interval, 0.81-0.93), a sensitivity of 96.0% (95% confidence interval, 89.0%-99.0%), and a specificity of 92.0% (95% confidence interval, 62.0-100.0). CONCLUSION: Comprehensive preoperative ultrasound can reasonably predict the appropriate surgical approach to placenta accreta spectrum. This can be achieved by assessing intracervical hypervascularity and urinary bladder wall distortion using a combination of transabdominal, transvaginal, and color Doppler ultrasound techniques because these signs have a strong correlation with the need for hysterectomy in a cohort for which the intended treatment was uterine-sparing surgery.
引用
- Aryananda RA, Adu-Bredu TK, Cininta NI, et al. Diagnostic ultrasound to inform the surgical approach to cesarean delivery in patients at high risk for placenta accreta spectrum disorders. Am J Obstet Gynecol. 2025. PMID: 40784608. doi:10.1016/j.ajog.2025.08.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。